Pressure Point Inc. Release: Story Optimal Antiemetic Non-Drug Substitute For Postoperative Nausea And Vomiting (PONV) Management

Published: Aug 02, 2017

Optimal Antiemetic Non-Drug Substitute for Postoperative Nausea and Vomiting (PONV) Management Use Solving the Protracted PONV Problem with Pressure-Applied Therapy Pressure Point Inc.,

Tinton Falls, NJ, announces an antiemetic non-drug substitute having the capacity to increase optimal PONV containment for surgical patients. The additive effects of the company’s antiemetic substitute of pressure-driven therapy acts as a non-pharmacologic agent to control the physiology of PONV. As a disposable device its continuing effect removes the immediate concerns of early and late nausea and vomiting after surgery.

As part of routine PONV therapy, the company’s Pressure Right® antiemetic non-pharmacologic device may be used on a singular basis (moderate risk) or as an adjunct therapy (high risk) adult patients 18 years and older.

The company’s (non-sterile) antiemetic non-pharmacologic substitute device provides 72-hours of comfortable and uninterrupted pressure therapy stimulation to provide essential and timely PONV optimal prevention without drug-related adverse side effects.

We are seeking worldwide distribution sources, headed up by individuals preferably having surgical or anesthesia experience, to join our global network of independent providers. Our company’s global medical non-pharmacologic substitute device (Pressure Right) represents an optimal change in PONV management healthcare solutions.

Contact Information:
Joseph DiLustro, CEO
Phone/Text: (908) 601-8877

Back to news